---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-257390"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2026-06-04T20:06:58+00:00"
generated_at: "2026-06-04T20:29:21.095820+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Amylyx stockholders elect directors, ratify auditor, approve say-on-pay at annual meeting

## Summary
- Elected George Mclean Milne Jr., Ph.D. (76.9M for, 14.1M withheld) and Paul Fonteyne (86.3M for, 4.8M withheld) as Class II directors.
- Ratified Deloitte & Touche as independent auditor for FY 2026: 102.0M for, 34.5K against, 5.6K abstain.
- Approved non-binding advisory vote on named executive officer compensation: 77.5M for, 13.5M against, 21.1K abstain.
- No other matters were voted on at the June 4, 2026 Annual Meeting.

## SEC filing metadata
- accession: 0001193125-26-257390
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2026-06-04T20:06:58+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312526257390/0001193125-26-257390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312526257390/d128401d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-257390
- JSON: https://secwatch.observer/filing/0001193125-26-257390.json
- Plain text: https://secwatch.observer/filing/0001193125-26-257390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.